The New Jersey Senate passed bipartisan legislation sponsored by Senator Declan O’Scanlon on Mar. 23 that would permit law enforcement officers to carry epinephrine.
The measure is intended to help police respond more effectively in emergencies involving severe allergic reactions, when quick access to medication can be critical. Police are often the first responders at emergency scenes, and the new bill aims to equip them with life-saving tools.
“Police officers are often the first to arrive on the scene, and in an emergency where every second counts, having access to life saving medicine like epinephrine can make all the difference,” said Senator O’Scanlon. “This is a commonsense bill that would enable law enforcement officers to be properly trained and equipped to respond to someone experiencing anaphylaxis.”
Under S-2551, O’Scanlon’s bill, police would have the opportunity to complete a training program on administering epinephrine and could carry at least one dose of it in their vehicles or medical kits. “Allowing police officers to carry epi-pens increases the chance of saving lives and ensures they can provide critical care when it is needed most,” O’Scanlon said.
Senator Anthony M. Bucco also plays a key role in legislative matters as he provides constituent services through his district office and email for legislative inquiries according to the official website. Bucco serves as a member of both the Senate Judiciary Committee and Senate Budget and Appropriations Committee according to the official website. He engages in sponsoring bills and contributing committee discussions on important state issues according to the official website.
Bucco holds leadership positions including Senate Republican Leader and chairs significant committees such as Judiciary while serving on Budget and Appropriations according to the official website. He represents New Jersey’s 25th Legislative District as senator according to the official website.
As lawmakers move forward with this initiative, supporters say expanding access for first responders could improve outcomes for those facing life-threatening allergic reactions.